#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.MedicalEntity|DCT|MedicalEntity
#T_RL=webanno.custom.TLINK|TLINK|BT_webanno.custom.MedicalEntity


#Text=15.03.2023:
#Text=Mann 48 år med residiverende sinusitt siste 2 år.
1-1	0-10	15.03.2023	_	_	_	_	
1-2	10-11	:	_	_	_	_	
1-3	12-16	Mann	_	_	_	_	
1-4	17-19	48	_	_	_	_	
1-5	20-22	år	_	_	_	_	
1-6	23-26	med	_	_	_	_	
1-7	27-40	residiverende	BEFOREOVERLAP[1]	CONDITION[1]	_	_	
1-8	41-49	sinusitt	BEFOREOVERLAP[1]	CONDITION[1]	_	_	
1-9	50-55	siste	_	_	_	_	
1-10	56-57	2	_	_	_	_	
1-11	58-60	år	_	_	_	_	
1-12	60-61	.	_	_	_	_	

#Text=Tett nese, facial smerte, purulent sekresjon.
2-1	62-66	Tett	OVERLAP[2]	CONDITION[2]	_	_	
2-2	67-71	nese	OVERLAP[2]	CONDITION[2]	_	_	
2-3	71-72	,	_	_	_	_	
2-4	73-79	facial	OVERLAP[3]	CONDITION[3]	_	_	
2-5	80-86	smerte	OVERLAP[3]	CONDITION[3]	_	_	
2-6	86-87	,	_	_	_	_	
2-7	88-96	purulent	OVERLAP[4]	CONDITION[4]	_	_	
2-8	97-106	sekresjon	OVERLAP[4]	CONDITION[4]	_	_	
2-9	106-107	.	_	_	_	_	

#Text=CT bihuler viser total fortetning av sinus maxillaris bilateralt.
3-1	108-110	CT	OVERLAP[5]	TREATMENT[5]	_	_	
3-2	111-118	bihuler	OVERLAP[5]	TREATMENT[5]	_	_	
3-3	119-124	viser	_	_	_	_	
3-4	125-130	total	_	_	_	_	
3-5	131-141	fortetning	OVERLAP[6]	CONDITION[6]	BEFORE	3-1[5_6]	
3-6	142-144	av	OVERLAP[6]	CONDITION[6]	_	_	
3-7	145-150	sinus	OVERLAP[6]	CONDITION[6]	_	_	
3-8	151-161	maxillaris	OVERLAP[6]	CONDITION[6]	_	_	
3-9	162-172	bilateralt	OVERLAP[6]	CONDITION[6]	_	_	
3-10	172-173	.	_	_	_	_	

#Text=Allergiscreening negativ.
4-1	174-190	Allergiscreening	OVERLAP	TREATMENT	_	_	
4-2	191-198	negativ	_	_	_	_	
4-3	198-199	.	_	_	_	_	

#Text=Starter Doksycyklin 100mg x1 i 14 dager.
5-1	200-207	Starter	_	_	_	_	
5-2	208-219	Doksycyklin	AFTER[7]	TREATMENT[7]	_	_	
5-3	220-225	100mg	AFTER[7]	TREATMENT[7]	_	_	
5-4	226-228	x1	_	_	_	_	
5-5	229-230	i	_	_	_	_	
5-6	231-233	14	_	_	_	_	
5-7	234-239	dager	_	_	_	_	
5-8	239-240	.	_	_	_	_	

#Text=Henviser ØNH.
6-1	241-249	Henviser	AFTER[8]	TREATMENT[8]	_	_	
6-2	250-253	ØNH	AFTER[8]	TREATMENT[8]	_	_	
6-3	253-254	.	_	_	_	_	
